Literature DB >> 21043998

Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix.

Bryan N Brown1, John M Freund, Li Han, J Peter Rubin, Janet E Reing, Eric M Jeffries, Mathew T Wolf, Stephen Tottey, Christopher A Barnes, Buddy D Ratner, Stephen F Badylak.   

Abstract

Extracellular matrix (ECM)-based scaffold materials have been used successfully in both preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. Results of numerous studies have shown that ECM scaffolds are capable of supporting the growth and differentiation of multiple cell types in vitro and of acting as inductive templates for constructive tissue remodeling after implantation in vivo. Adipose tissue represents a potentially abundant source of ECM and may represent an ideal substrate for the growth and adipogenic differentiation of stem cells harvested from this tissue. Numerous studies have shown that the methods by which ECM scaffold materials are prepared have a dramatic effect upon both the biochemical and structural properties of the resultant ECM scaffold material as well as the ability of the material to support a positive tissue remodeling outcome after implantation. The objective of the present study was to characterize the adipose ECM material resulting from three methods of decellularization to determine the most effective method for the derivation of an adipose tissue ECM scaffold that was largely free of potentially immunogenic cellular content while retaining tissue-specific structural and functional components as well as the ability to support the growth and adipogenic differentiation of adipose-derived stem cells. The results show that each of the decellularization methods produced an adipose ECM scaffold that was distinct from both a structural and biochemical perspective, emphasizing the importance of the decellularization protocol used to produce adipose ECM scaffolds. Further, the results suggest that the adipose ECM scaffolds produced using the methods described herein are capable of supporting the maintenance and adipogenic differentiation of adipose-derived stem cells and may represent effective substrates for use in tissue engineering and regenerative medicine approaches to soft tissue reconstruction.

Mesh:

Substances:

Year:  2011        PMID: 21043998      PMCID: PMC3065729          DOI: 10.1089/ten.TEC.2010.0342

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  40 in total

1.  Antimicrobial activity associated with extracellular matrices.

Authors:  Ayda Sarikaya; Rae Record; Ching-Ching Wu; Bob Tullius; Stephen Badylak; Michael Ladisch
Journal:  Tissue Eng       Date:  2002-02

2.  Assessing porcine liver-derived biomatrix for hepatic tissue engineering.

Authors:  Paul Lin; Warren C W Chan; Stephen F Badylak; Sangeeta N Bhatia
Journal:  Tissue Eng       Date:  2004 Jul-Aug

3.  Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study.

Authors:  Jolene E Valentin; John S Badylak; George P McCabe; Stephen F Badylak
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

Review 4.  Autologous fat transfer: an in-depth look at varying concepts and techniques.

Authors:  Kimberly J Butterwick; Pavan K Nootheti; Jessica W Hsu; Mitchel P Goldman
Journal:  Facial Plast Surg Clin North Am       Date:  2007-02       Impact factor: 1.918

5.  Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Authors:  A J Allman; T B McPherson; S F Badylak; L C Merrill; B Kallakury; C Sheehan; R H Raeder; D W Metzger
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

6.  Identification and characterization of bioactive factors in bladder submucosa matrix.

Authors:  So Young Chun; Grace Jeong Lim; Tae Gyun Kwon; Eun Kyoung Kwak; Bup Wan Kim; Anthony Atala; James J Yoo
Journal:  Biomaterials       Date:  2007-07-06       Impact factor: 12.479

7.  Macrophage phenotype as a determinant of biologic scaffold remodeling.

Authors:  Stephen F Badylak; Jolene E Valentin; Anjani K Ravindra; George P McCabe; Ann M Stewart-Akers
Journal:  Tissue Eng Part A       Date:  2008-11       Impact factor: 3.845

8.  Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet.

Authors:  Jun Liao; Erinn M Joyce; Michael S Sacks
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

9.  Altered structural and mechanical properties in decellularized rabbit carotid arteries.

Authors:  C Williams; J Liao; E M Joyce; B Wang; J B Leach; M S Sacks; J Y Wong
Journal:  Acta Biomater       Date:  2008-12-11       Impact factor: 8.947

10.  Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix.

Authors:  Ellen P Brennan; Janet Reing; Douglas Chew; Julie M Myers-Irvin; E J Young; Stephen F Badylak
Journal:  Tissue Eng       Date:  2006-10
View more
  52 in total

1.  Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration.

Authors:  Udi Sarig; Gigi C T Au-Yeung; Yao Wang; Tomer Bronshtein; Nitsan Dahan; Freddy Y C Boey; Subbu S Venkatraman; Marcelle Machluf
Journal:  Tissue Eng Part A       Date:  2012-07-19       Impact factor: 3.845

2.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

3.  Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells.

Authors:  Guiting Lin; Maarten Albersen; Ahmed M Harraz; Thomas M Fandel; Maurice Garcia; Mary H McGrath; Badrinath R Konety; Tom F Lue; Ching-Shwun Lin
Journal:  Urology       Date:  2011-04-13       Impact factor: 2.649

4.  Decellularized extracellular matrix derived from porcine adipose tissue as a xenogeneic biomaterial for tissue engineering.

Authors:  Young Chan Choi; Ji Suk Choi; Beob Soo Kim; Jae Dong Kim; Hwa In Yoon; Yong Woo Cho
Journal:  Tissue Eng Part C Methods       Date:  2012-07-02       Impact factor: 3.056

Review 5.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

Review 6.  Repopulation of decellularized whole organ scaffold using stem cells: an emerging technology for the development of neo-organ.

Authors:  Aleem Ahmed Khan; Sandeep Kumar Vishwakarma; Avinash Bardia; J Venkateshwarulu
Journal:  J Artif Organs       Date:  2014-07-17       Impact factor: 1.731

7.  Studying Normal Tissue Radiation Effects using Extracellular Matrix Hydrogels.

Authors:  Steven M Alves; Tian Zhu; Anastasia Shostak; Ninna S Rossen; Marjan Rafat
Journal:  J Vis Exp       Date:  2019-07-24       Impact factor: 1.355

8.  Approaches to improve integration and regeneration of an ex vivo derived temporomandibular joint disc scaffold with variable matrix composition.

Authors:  Andrea M Matuska; M Franklin Dolwick; Peter S McFetridge
Journal:  J Mater Sci Mater Med       Date:  2018-09-27       Impact factor: 3.896

9.  Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation.

Authors:  M Caralt; J S Uzarski; S Iacob; K P Obergfell; N Berg; B M Bijonowski; K M Kiefer; H H Ward; A Wandinger-Ness; W M Miller; Z J Zhang; M M Abecassis; J A Wertheim
Journal:  Am J Transplant       Date:  2014-11-17       Impact factor: 8.086

10.   Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior.

Authors:  Madeline C Cramer; Stephen F Badylak
Journal:  Ann Biomed Eng       Date:  2019-11-18       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.